西亚试剂：Stem-cell success poses immunity challenge for diabetes

发布时间：2025-05-31

Each year, surgeon Jose Oberholzer frees a few people with type 1 diabetes from daily insulin injections by giving them a transplant of the insulin-secreting β-cells that the disease attacks. But it is a frustrating process. Harvested from a cadaver’s pancreas, the β-cells are in short supply and vary in quality. And the patients must take drugs to suppress their immune response to the foreign cells, which can in turn cause kidney failure.

以上资料由西亚试剂：http://www.xiyashiji.com/ 提供

上一篇：西亚试剂：年龄依赖性的胰岛δ细胞可转化为胰岛素生产商
下一篇：西亚试剂:中国引领造出超级新材料